Trial intelligence / Profile preview

Myoinositol vs Metformin in Infertile PCOS Women

NCT07058675Completed

Sponsor
Benha University
Start
Nov 2024
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of myo-inositol in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Benha University. Primary endpoint: Success Rate of Treatment Regimens in Restoring Menstrual Regularity and/or Achieving Pregnancy. Started Nov 2024; status: completed.

02

Drugs

myo-inositol
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT07058675.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07058675.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call